遇见数据集

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC

收藏
NIAID Data Ecosystem2026-03-06 收录
官方服务:

资源简介:

This phase III study will compare two combinations of irinotecan, Folfiri versus Xeliri, with the addition of Avastin as 1st line treatment of colorectal cancer.

创建时间:
2006-12-15
二维码
社区交流群
二维码
科研交流群
商业服务